John Powers III takes the permanent helm of the National Institute of Allergy and Infectious Diseases after Jeanne Marrazzo was pushed out over objections to grant terminations. Prior to his permanent appointment, Powers collaborated with agency director Jay Bhattacharya on a paper urging a shift away from pandemic preparedness and HIV toward general immunology. Meanwhile, federal public health faces additional shifts, as experts warn that Health Secretary Robert F. Kennedy Jr.'s support for non-traditional wellness farms could divert grant funding from approved addiction medications like methadone.
Key points
Leadership changes at the agency reflect an intentional policy shift away from prioritizi…: Leadership changes at the agency reflect an intentional policy shift away from prioritizing pandemic preparedness and HIV research.
Health experts caution that federal funding might be channeled to facilities that restric…: Health experts caution that federal funding might be channeled to facilities that restrict access to approved addiction treatments like methadone.
A federal judge eliminated a Trump administration policy that attempted to restrict the l…: A federal judge eliminated a Trump administration policy that attempted to restrict the length of stay for foreign students and scholars.
Sources checked by our analysis pipeline: 1
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
Good morning and happy Tuesday! Today’s newsletter includes good news for international students, bad news for the makers of signs proclaiming “zero tolerance” for violence in hospitals, and mixed news for children with rare brain disorders. Read on!
NIH’s infectious disease unit has a new head
No branch of the NIH has faced more scrutiny than the National Institute of Allergy and Infectious Diseases. For nearly four decades, the institute was run by Anthony Fauci; it’s since become a major focus of Republicans looking to re-litigate the Covid pandemic.
The institute has been without a permanent director since Jeanne Marrazzo was forced out in 2025 for objecting to grant terminations. Now officials have announced that acting director John Powers III will take the lead role.
Powers is a physician-scientist who’s worked at NIAID in several clinical research positions. He has run the institute in an acting capacity since June. Earlier this year, he co-authored a paper with NIH director Jay Bhattacharya…
British health authorities have chosen to waive an approaching break clause that would have permitted an early departure from the massive data analytics agreement. This decision ensures that the technology firm remains an integral data partner for the healthcare system across the latter half of the decade. The shift establishes an expected five-year operational horizon rather than an immediate exit.
Palestinian officials and the Israeli military have offered starkly conflicting accounts following a fatal confrontation linked to a newly established settler outpost in al-Duyuk al-Tahta. While local reports state Israeli settlers initiated gunfire outside a family residence, the Israel Defense Forces maintained that Israelis discharged weapons in self-defense following a deliberate vehicle ramming and physical assault. The deadly event coincides with mounting international scrutiny and fresh British economic pen…
British ministers declined an option to exit the £330m healthcare agreement next year, choosing instead to initiate a fresh procurement process next summer that invites domestic companies to bid for work beginning later in the decade. The decision seeks to prevent single-supplier dependence while keeping software deployed to address persistent hospital backlogs. However, the continuation faces intense political scrutiny regarding patient confidentiality and the American firm's outside defence ties.